Biopharmaceutical Processing Equipment and Consumables Market Size was valued at USD 44.1 Bn in 2023 and is predicted to reach USD 85.7 Bn by 2031 at a 8.84% CAGR during the forecast period for 2024-2031.
Biopharmaceutical processing equipment and consumables are the goods or gadgets utilized in the production of biopharmaceuticals. The production of drugs from organic or partially artificial sources using various processed tools, such as filtration systems, bioreactors, and division methods, is referred to as biopharmaceutical production. The primary force behind market growth in the biopharmaceutical sector is the growing emphasis on regulatory compliance and quality. Global regulatory agencies have established stringent policies and procedures about the production and handling of biopharmaceuticals. Because of this, there is now a higher need for premium supplies and equipment that satisfy these strict specifications. In response to this need, manufacturers allocate resources toward compliance initiatives, examinations, and surveillance systems. As producers prioritize producing secure and efficient biopharmaceuticals, the industry for consumable biopharmaceutical processing equipment is predicted to expand.
However, the expensive requirements for the security and well-being of the biopharmaceutical processing equipment and consumables industry and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high-low code technology in insurance because of the lack of payment criteria and adequate insurance coverage, the therapeutic procedures have become prohibitively expensive. Biopharmaceutical processing equipment consumption can be expensive, particularly for specialized and cutting-edge goods. Rising expenses may restrict access to novel consumables for less extensive biopharmaceutical businesses or those with fewer expenditures. The COVID-19 epidemic has affected the market, leading to the shutdown of multiple firms to prevent viral transmission among employees. This could impede the industry's growth.
The biopharmaceutical processing equipment and consumables market is segmented based on product type, application, and end user. Based on product type, the market is segmented into filtration, chromatography, bioreactors, cell culture media, mixing systems, bioprocessing containers, sterilizers, centrifuges, incubators, shakers, biosafety cabinets, other equipment and consumables, as well as various services. The market is segmented based on application into commercial bioproduction, vaccine manufacturing, mAb production, recombinant protein production, cell and gene therapy production, and research bioproduction. The market is segmented by end-users into pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and academia and research institutes.
Filtration is expected to hold a major global market share in 2023 in the biopharmaceutical processing equipment and consumables market. It is the fundamental requirement for every step of the biotechnology method. In the manufacturing of biopharmaceuticals, filtration is frequently employed to separate constituents. It is utilized in several downstream processes, including clarifying, transitional filtration, crucial finishing filling programs, and initial culture media filtration for sanitizing purposes.
Academia and research institutes use acrylic acid ester mainly because they create novel biological goods and undertake investigations to contribute to the market's growth. Government organizations are essential in overseeing the biopharmaceutical sector and supplying capital for R&D initiatives, especially in countries like the US, Germany, the UK, China, and India.
The North American biopharmaceutical processing equipment and consumables market is expected to register the highest market share in revenue in the near future. It can be attributed to the prevalence of chronic diseases, high and rising healthcare expenditure, an advanced healthcare infrastructure, available reimbursements, and the presence of major market players. In addition, Asia Pacific is projected to grow rapidly in the global biopharmaceutical processing equipment and consumables market due to the huge amount of registered clinical trials linked to the treatments. Additionally, the market is expanding more quickly due to rising awareness of customized medications and the creation of biotechnology startups.
Report Attribute |
Specifications |
Market Size Value In 2023 |
USD 44.1 Bn |
Revenue Forecast In 2031 |
USD 85.7 Bn |
Growth Rate CAGR |
CAGR of 8.84% from 2024 to 2031 |
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
Historic Year |
2019 to 2023 |
Forecast Year |
2024-2031 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
By Product Type, By Application, By End-user and By Region |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
Competitive Landscape |
3M Company, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Agilent Technologies, Inc., Repligen Corporation, Sartorius AG, Merck KGaA, Eppendorf AG, Solaris Biotechnology Srl, and Other Prominent Players. |
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biopharmaceutical Processing Equipment and Consumables Market Snapshot
Chapter 4. Global Biopharmaceutical Processing Equipment and Consumables Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product Type:
5.2.1. Filtration Systems
5.2.2. Chromatography Equipment and Consumables
5.2.3. Consumables
5.2.4. Equipment
5.2.5. Bioreactors
5.2.6. Reusable Bioreactors
5.2.7. Disposable/Single-use Bioreactors
5.2.8. Cell Culture Products
5.2.9. Cell Culture Media
5.2.9.1. Cell Culture Media, by Physical Form
5.2.9.1.1. Dry Powder Media
5.2.9.1.2. Liquid Media
5.2.9.2. Cell Culture Media, by Type
5.2.9.2.1. Off-the-Shelf Media
5.2.9.2.2. Custom Media
5.2.9.3. Cell Culture Media, by Source
5.2.9.3.1. Chemically Defined Media
5.2.9.3.2. Natural Media
5.2.10. Reagents and Supplements
5.2.11. Cell and Cell Lines
5.2.12. Serum
5.2.13. Mixing Systems
5.2.14. Bioprocessing Containers
5.2.15. Sterilizers
5.2.16. Centrifuges
5.2.17. Incubators
5.2.18. Shakers
5.2.19. Biosafety Cabinets
5.2.20. Other Equipment and Consumables
5.2.21. Services
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:
6.2.1. Commercial Bioproduction
6.2.2. Vaccine Manufacturing
6.2.3. mAb Production
6.2.4. Recombinant Protein Production
6.2.5. Cell and Gene Therapy Production
6.2.6. Research Bioproduction
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. By End User & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End User:
7.2.1. Pharmaceutical and Biopharmaceutical Companies
7.2.2. Contract Development and Manufacturing Organizations (CDMOs)
7.2.3. Academia and Research Institutes
Chapter 8. Biopharmaceutical Processing Equipment and Consumables Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.1.2. North America Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.1.3. North America Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.1.4. North America Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.2.2. Europe Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.2.3. Europe Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.2.4. Europe Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.3.2. Asia Pacific Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.3.3. Asia Pacific Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.3.4. Asia Pacific Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Asia Pacific Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.4.2. Latin America Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.4.3. Latin America Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.4.4. Latin America Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.5.2. Middle East & Africa Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.5.3. Middle East & Africa Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.5.4. Middle East & Africa Biopharmaceutical Processing Equipment and Consumables Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. 3M Company (U.S.),
9.2.2. Thermo Fisher Scientific, Inc. (U.S.),
9.2.3. Bio-Rad Laboratories, Inc. (U.S.),
9.2.4. Danaher Corporation (U.S.),
9.2.5. Agilent Technologies, Inc (U.S.),
9.2.6. Repligen Corporation (U.S.),
9.2.7. Sartorius AG (Germany),
9.2.8. Merck KGaA (Germany),
9.2.9. Eppendorf AG (Germany),
9.2.10. Solaris Biotechnology Srl (Italy).
9.2.11. Other Prominent Players
Biopharmaceutical Processing Equipment and Consumables Market- By Product Type
Biopharmaceutical Processing Equipment and Consumables Market- By Application
Biopharmaceutical Processing Equipment and Consumables Market- By End User
Biopharmaceutical Processing Equipment and Consumables Market- By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.